Ok. Gong
JPMorgan Chase & Co, Analysis Division
Okay. Thanks, everybody, for coming at this time. My identify is Allen Gong, right here on the JPMorgan Medtech group. I am actually excited to have the administration group of iRhythm right here at this time this morning. We’ll begin off with some ready remarks from CEO, Quentin Blackford, after which we’ll tag in Dan Wilson, CFO, for some Q&A after that. So Quentin, for those who might begin us off.
Quentin Blackford
President, CEO & Director
Terrific. Are you able to guys hear me okay? Thanks for having us, Allen. We respect the chance to be right here. We’re excited to be right here, coming off of an unbelievable 2025 for iRhythm, and we’re wanting ahead to an much more thrilling 2026. As we glance forward, only a fast reminder, I will likely be utilizing forward-looking statements in the course of the course of this morning’s presentation. I would refer you to our firm web site, firm filings for any additional data that you just is perhaps in search of there.
When a sign modifications all the pieces, once we discuss alerts in arrhythmias, we’re not speaking about simply anybody specific factor, sign present up in quite a lot of alternative ways. And it is the complexity of that, that creates the problem for gamers on this house, for us, it additionally turns into the chance. We take into consideration how these alerts present up in apply each day, generally it is a story like Carissa, who finds herself within the ER, coping with extreme well being points, solely to have an EKG carried out and advised her that all the pieces is completely fantastic. She is shipped dwelling, no points. She finds
